Insulet Stock Forecast
NASDAQ: PODDHealth CareMedical/Dental InstrumentsUSD
Market open · Delayed 15 min · as of Oct 8, 11:17 AM ET
PODD analyst consensus
Consensus (26 analysts)
buy
Avg. price target
$170.96+28.03%
- Strong buy 4
- Buy 11
- Hold 11
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 26 Wall Street analysts covering Insulet (2026-10-07), 15 rate the stock a buy or strong buy, 11 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $170.96, with a high estimate of $275.00 and a low estimate of $144.00. The average target implies upside of 28.0% from the current price of $133.54.
The spread between the highest and lowest targets is 91.0%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for PODD.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 4 | 15% |
| Buy | 11 | 42% |
| Hold | 11 | 42% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $144.00 | +7.84% |
| Average target | $170.96 | +28.03% |
| High target | $275.00 | +105.94% |